p21(WAF1/CIP1) expression in non-melanoma skin tumors

被引:21
作者
Ahmed, NU [1 ]
Ueda, M [1 ]
Ichihashi, M [1 ]
机构
[1] KOBE UNIV,SCH MED,DEPT DERMATOL,CHUO KU,KOBE 650,JAPAN
关键词
D O I
10.1111/j.1600-0560.1997.tb01585.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Abnormal control of die cell cycle is closely linked to carcinogenesis. p21(WAF1/CIP1) protein is a universal inhibitor of G1 cyclin-dependent kinase and is induced by p53-dependent and -independent pathways. In order to elucidate the role of p21(WAF1/CIP1) in human skin carcinogenesis, protein expression in squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Bowen's disease (BD), actinic keratosis (AK), keratoacanthoma (KA), seborrheic keratosis (SK), and normal skin was examined using an immunohistochemical method. In normal skin, a few positive cells were seen in some cases in the upper spinous layer of the epidermis; sebaceous glands also had positive cells. In cases of SK and KA, positive cells were found in the basal and suprabasal epidermal layers (proliferation pattern), and in cases of ED and AK, positive cells were seen mainly in the upper spinous layer (differentiation pattern). Cases of SCC had more positive cells and showed two staining patterns: proliferation, or mixed. Cases of BCC had no positive cells. p21(WAF1/CIP1) has some unidentified role in keratinocyte tumorigenesis, which may not be related directly to carcinogenesis.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 19 条
[1]   EXPRESSION OF P21(WAF1/CIP1) IS HETEROGENEOUS AND UNRELATED TO PROLIFERATION INDEX IN HUMAN OVARIAN-CARCINOMA [J].
BARBOULE, N ;
MAZARS, P ;
BALDIN, V ;
VIDAL, S ;
JOZAN, S ;
MARTEL, P ;
VALETTE, A .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (05) :611-615
[2]   CYCLIN-D AND RETINOBLASTOMA GENE-PRODUCT EXPRESSION IN ACTINIC KERATOSIS AND CUTANEOUS SQUAMOUS-CELL CARCINOMA IN RELATION TO P53 EXPRESSION [J].
BITO, T ;
UEDA, M ;
AHMED, NU ;
NAGANO, T ;
ICHIHASHI, M .
JOURNAL OF CUTANEOUS PATHOLOGY, 1995, 22 (05) :427-434
[3]  
DIGIUSEPPE JA, 1995, AM J PATHOL, V147, P884
[4]  
EASTHAM JA, 1995, CANCER RES, V55, P5151
[5]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[6]  
ELDEIRY WS, 1995, CANCER RES, V55, P2910
[7]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[8]  
HARPER JW, 1993, CELL, V75, P805
[9]  
HEARLY E, 1995, J INVEST DERMATOL, V105, P274
[10]  
JUNG JM, 1995, ONCOGENE, V11, P2021